NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
Description
The National Cancer Institute (NCI) is offering funding to support innovative exploratory research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This includes clinical trials, studies related to clinical trials, and the development of new cancer treatments and preventive measures. The grant focuses on early-stage projects that might be risky but have the potential for significant breakthroughs in cancer research, particularly in creating new techniques or model…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; n…
Source
Grant ID
PAR-25-139
Agency
Department of Health and Human Services
Subcategory/Subagency
National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- City or township governments
- Public and State controlled institutions of higher education
- For profit organizations other than small businesses
- Public housing authorities/Indian housing authorities
- Native American tribal governments (Federally recognized)
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- County governments
- Special district governments
- State governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- Independent school districts
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Private institutions of higher education
- Small businesses
Awards & Funding
Total Funding
$200,000
Award Ceiling
$275,000
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- Exploratory/Developmental Research Grant Program (R21)
National Institutes of Health
- Notice of Funding Opportunity for Research on Adverse Sequelae of Cancer Therapies
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Revision Applications to Accelerate the Translation of NCI-Supported Methods/Assays/Technologies to the Clinic
National Institutes of Health
- Exploratory Research Projects for Innovative Molecular Analysis Technologies in Cancer Research
National Institutes of Health
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Department of Health and Human Services